Laboratorios Ordesa plans to grow through acquisitions in the pharmaceutical sector
Laboratorios Ordesa planea crecer mediante adquisiciones en el sector farmacéutico
Intel ID : 403723
|
||||
| Intel ID | 403723 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Laboratorios Ordesa
(31 Dec 2021) |
Revenue: EUR 123,19m EBITDA: EUR 3,43m Net Debt: EUR 166,49m People: 302 |
|
| Date |
 |
|
| Country | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Primary Subsector (TTRSC) |
15.07.07 Health Food & Supplements (Primary) 15 Consumer Products & Services / 15.07 Food |
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
 |
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
15.07.07 Health Food & Supplements 15 Consumer Products & Services / 15.07 Food |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.